Cargando…

Polymorphisms of the stem cell marker gene CD133 are associated the clinical outcome in a cohort of Chinese non-small cell lung cancer patients

OBJECTIVES: To evaluate the prognostic relevance of four functional single nucleotide polymorphisms (SNPs) in CD133 (rs2240688A>C, rs10022537T>A, rs7686732C>G, and rs3130C>T) on overall survival (OS) of non-small cell lung cancer (NSCLC) patients. DESIGN: Retrospective cohort study. SETT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Qing-Feng, Zhang, Zhi-Fei, Hou, Guang-Jie, Yang, Guang-Yu, He, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724226/ https://www.ncbi.nlm.nih.gov/pubmed/28827262 http://dx.doi.org/10.1136/bmjopen-2017-016913

Ejemplares similares

Role of CD133/NRF2 Axis in the Development of Colon Cancer Stem Cell-Like Properties
por: Park, Jimin, et al.
Publicado: (2022)

CD133, Stem Cells, and Cancer Stem Cells: Myth or Reality?
por: Yu, Xiazhen, et al.
Publicado: (2011)

Prognostic Value of Cancer Stem Cell Marker CD133 Expression in Gastric Cancer: A Systematic Review
por: Wen, Lei, et al.
Publicado: (2013)

Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma
por: ZHOU, FEI, et al.
Publicado: (2014)

Correction: Prognostic Value of Cancer Stem Cell Marker CD133 Expression in Gastric Cancer: A Systematic Review
por: Wen, Lei, et al.
Publicado: (2014)

Suitability of CD133 as a Marker for Cancer Stem Cells in Melanoma
por: Korn, Philippe, et al.
Publicado: (2021)

Immunohistochemical Expression of the Stem Cell Marker CD133 in Colorectal Carcinoma
por: Suman, Sweta, et al.
Publicado: (2023)

A comprehensive promoter landscape identifies a novel promoter for CD133 in restricted tissues, cancers, and stem cells
por: Sompallae, Ramakrishna, et al.
Publicado: (2013)

Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma
por: Nosrati, Anahita, et al.
Publicado: (2014)

Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer
por: WANG, CHUNXIA, et al.
Publicado: (2012)

CD133 in Breast Cancer Cells: More than a Stem Cell Marker
por: Brugnoli, Federica, et al.
Publicado: (2019)

Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
por: Immervoll, Heike, et al.
Publicado: (2008)

Molecular Regulation of Autophagy and Asymmetric Cell Division by Cancer Stem Cell Marker CD133
por: Izumi, Hideki, et al.
Publicado: (2023)

CD133 Is a Marker For Long-Term Repopulating Murine Epidermal Stem Cells
por: Charruyer, A, et al.
Publicado: (2012)

Clinical Significance of Cancer Stem Cell Markers CD133 and CXCR4 in Osteosarcomas
por: Mardani, Azam, et al.
Publicado: (2020)

ARE STEM CELL MARKER EXPRESSION AND CD133 ANALYSIS RELEVANT TO DIFFERENTIATE COLORECTAL CANCER?
por: CZECZKO, Leticia Elizabeth Augustin, et al.
Publicado: (2021)

ARE STEM CELL MARKER EXPRESSION AND CD133 ANALYSIS RELEVANT TO DIFFERENTIATE COLORECTAL CANCER?
por: CZECZKO, Leticia Elizabeth Augustin, et al.
Publicado: (2021)

Expression of CD133 as a cancer stem cell marker in invasive gastric carcinoma
por: Attia, S., et al.
Publicado: (2019)

Tumour stem cell markers CD133 and CD44 are useful prognostic factors after surgical resection of pancreatic neuroendocrine tumours
por: Sun, Zhonghai, et al.
Publicado: (2020)

Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma
por: Wang, Jian‐Hua, et al.
Publicado: (2019)

Endothelial Cell-Derived TGF-β Promotes Epithelial-Mesenchymal Transition via CD133 in HBx-Infected Hepatoma Cells
por: Rawal, Preety, et al.
Publicado: (2019)

The Stem Cell Marker CD133 Associates with Enhanced Colony Formation and Cell Motility in Colorectal Cancer
por: Elsaba, Tarek M. A., et al.
Publicado: (2010)

CD133 Is Not Suitable Marker for Isolating Melanoma Stem Cells from D10 Cell Line
por: Rajabi Fomeshi, Motahareh, et al.
Publicado: (2016)

CD133: a stem cell biomarker and beyond
por: Li, Zhong
Publicado: (2013)

Prostate Cancer Stem Cells: The Role of CD133
por: Yang, Jianhui, et al.
Publicado: (2022)

Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis
por: Hong, Injae, et al.
Publicado: (2015)

Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53
por: Park, E K, et al.
Publicado: (2015)

The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients
por: Chen, Yao-Li, et al.
Publicado: (2017)

Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma
por: Rezaee, Maryam, et al.
Publicado: (2021)

CD133 Antigen as a Potential Marker of Melanoma Stem Cells: In Vitro and In Vivo Studies
por: Kloskowski, Tomasz, et al.
Publicado: (2020)

Is CD133 Expression a Prognostic Biomarker of Non-Small-Cell Lung Cancer? A Systematic Review and Meta-Analysis
por: Wu, Hong, et al.
Publicado: (2014)

Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57
por: Zhu, Xuekai, et al.
Publicado: (2014)

Genomic profiles of renal cell carcinoma in a small Chinese cohort
por: Tai, Sheng, et al.
Publicado: (2023)

Significance of CD133 as a cancer stem cell markers focusing on the tumorigenicity of pancreatic cancer cell lines
por: Lee, Hyun Joo, et al.
Publicado: (2011)

Immunohistochemical Detection of Cancer Stem Cell Related Markers CD44 and CD133 in Metastatic Colorectal Cancer Patients
por: Pitule, Pavel, et al.
Publicado: (2014)

Biological characteristics of CD133(+) cells in nasopharyngeal carcinoma
por: ZHUANG, HUI-WEN, et al.
Publicado: (2013)

Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer
por: Pellacani, Davide, et al.
Publicado: (2011)

Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients
por: Zhang, Mingyu, et al.
Publicado: (2008)

The Cancer Stem Cell Marker CD133 Interacts with Plakoglobin and Controls Desmoglein-2 Protein Levels
por: Koyama-Nasu, Ryo, et al.
Publicado: (2013)

Evaluation of immunohistochemical expression of stem cell markers (NANOG and CD133) in normal, hyperplastic, and malignant endometrium
por: Al-Kaabi, Methaq, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kamf9nt94m4r1gegug6h34799d